#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Uterine leiomyosarcoma Hereditary hypophosphataemic rickets Neurodegenerative disorder Myotonia Chondrodystrophy Fibrous dysplasia of bone Amyotrophic lateral sclerosis Mixed-type liposarcoma Hydrocephalus Neuromyelitis optica spectrum disorder Follicular lymphoma stage II Vulval cancer Rhabdoid tumour SAPHO syndrome Amyloidosis More trials…
Learn about Rare Diseases

Niemann-Pick disease – Diagnostics Vascular malformation – Diagnostics Chondrosarcoma – Basic Information Prader-Willi syndrome – Diagnostics Pelizaeus-Merzbacher disease Congenital generalised lipodystrophy Kearns-Sayre syndrome – Basic Information Noonan syndrome – Treatment Leiomyosarcoma recurrent – Life with Disease Idiopathic pulmonary fibrosis – Treatment More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

GSKVX000000030810 Aficamten ISPAGHULA HUSK CHLOROQUINE PHOSPHATE Ttf-Ngr Vortioxetine Cl-Ad-Msc-002 Progesterone Bupivacaine Hydrochloride Ticagrelor Amisulpride Gremubamab Teverelix BI-1607 Macitentan Levothyroxine Bms-986315 AZD0292 CARBACHOL Selatogrel More therapies…

Learn about Your Condition

Sarcoma Decreased appetite Sickle cell anaemia Univentricular heart Phaeochromocytoma Staphylococcal infection Conjunctivitis Naevoid melanoma Thymoma malignant Procedural pain Neuroblastoma recurrent Colon cancer stage III Carotid arteriosclerosis Nicotine dependence Migraine More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Pneumococcal immunisation

Study on Pneumococcal Vaccine Response in Healthy Volunteers Using Pneumococcal Polysaccharide Conjugate Vaccine and Drug Combination

Recruiting

2 1 1 1
Investigated Drugs:
Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

Not yet recruiting

3 1 1 1
Investigated Drugs:
+1
Study of 20-valent pneumococcal conjugate vaccine (PCV20) booster response in healthy adults aged 78-84 years

Not recruiting

3 1 1 1
Investigated Drugs:
Study on the Safety and Immune Response of a 21-Valent Pneumococcal Vaccine in Healthy Infants, Toddlers, Children, and Adolescents

Not recruiting

3 1 1
Investigated Drugs:
Study on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

Not recruiting

3 1 1 1
Investigated Drugs:
+3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Pneumococcal immunisation

Study on Pneumococcal Vaccine Response in Healthy Volunteers Using Pneumococcal Polysaccharide Conjugate Vaccine and Drug Combination

Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

Study of 20-valent pneumococcal conjugate vaccine (PCV20) booster response in healthy adults aged 78-84 years

Study on the Safety and Immune Response of a 21-Valent Pneumococcal Vaccine in Healthy Infants, Toddlers, Children, and Adolescents

Study on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies